Citadel Advisors »

Cns Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Cns Pharmaceuticals (CNSP) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Cns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cns Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cns Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $33k 91k 0.36
2023-03-31 $13k 13k 1.00

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Cns Pharmaceuticals

Armistice Capital
Virtu Financial
Citadel Advisors
Smith Anglin Financial
Vanguard Group
Geode Capital Management
Jane Street
Hrt Financial
Two Sigma Securities
XTX Topco
Tower Research Capital
Bank of America Corporation
Wells Fargo & Company
Morgan Stanley
Global Retirement Partners

View all funds holding Cns Pharmaceuticals